Nihon Kohden Corporation (JP:6849)
:6849
Want to see JP:6849 full AI Analyst Report?
6849 Stock Chart & Stats
¥1683.00
-¥5.00(-0.24%)
At close: 4:00 PM EST
¥1683.00
-¥5.00(-0.24%)
Day’s Range― - ―
52-Week Range¥1,415.50 - ¥1,885.50
Previous CloseN/A
Volume364.00K
Average Volume (3M)516.53K
Market Cap
¥243.07B
Enterprise Value¥216.37B
Total Cash (Recent Filing)¥44.00B
Total Debt (Recent Filing)¥25.55B
Price to Earnings (P/E)36.4
Beta0.85
Next Earnings
May 14, 2026EPS Estimate
33.97Next Dividend Ex-DateN/A
Dividend Yield1.92%
Share Statistics
EPS (TTM)11.57
Shares Outstanding170,961,960
10 Day Avg. Volume572,580
30 Day Avg. Volume516,533
Financial Highlights & Ratios
PEG Ratio-1.46
Price to Book (P/B)1.85
Price to Sales (P/S)1.48
P/FCF Ratio40.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)96.67
Revenue Forecast (FY)¥231.47B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained TTM revenue growth of ~8.7% signals durable demand for hospital and acute-care equipment. Over 2–6 months this supports expansion of the installed base, stronger service/consumable pull-through, and provides a foundation for steady recurring revenue beyond one-time capital sales.
Conservative Balance SheetA low debt-to-equity ratio (~0.15) and sizable equity base preserve financial flexibility for R&D, capex or targeted M&A. This conservative structure reduces refinancing risk and supports multi-quarter resilience if cash flows fluctuate or procurement timing shifts in healthcare customers.
Installed-base Driven Recurring RevenueRevenue mix includes consumables, service contracts and device maintenance tied to an installed base, creating recurring streams less sensitive to single-equipment sales cycles. This structurally stabilizes revenue and improves lifetime customer value over multiple quarters.
Bears Say
Weak Free-cash-flow GrowthDespite positive operating cash (~¥21.5B) and FCF (~¥13.2B), FCF growth is sharply negative and conversion is only ~61% of net income. Persistent FCF volatility can limit reinvestment, constrain dividend or buyback plans, and reduce buffer for unexpected spending.
Margin CompressionNet margin contraction to ~5.4% and lower operating margins versus historical levels indicate rising costs or adverse mix. Sustained margin pressure erodes earnings power, reduces internal funding for R&D and services, and weakens resilience to pricing or procurement headwinds.
Rising Leverage Vs Prior YearsA recent step-up in debt from near-zero to D/E ~0.15 modestly reduces balance-sheet flexibility. If cash-flow volatility persists, incremental leverage may limit strategic options and increase sensitivity to interest or refinancing needs over the medium term.
Nihon Kohden Corporation News
6849 FAQ
What was Nihon Kohden Corporation’s price range in the past 12 months?
Nihon Kohden Corporation lowest stock price was ¥1415.50 and its highest was ¥1885.50 in the past 12 months.
What is Nihon Kohden Corporation’s market cap?
Nihon Kohden Corporation’s market cap is ¥243.07B.
When is Nihon Kohden Corporation’s upcoming earnings report date?
Nihon Kohden Corporation’s upcoming earnings report date is May 14, 2026 which is in 16 days.
How were Nihon Kohden Corporation’s earnings last quarter?
Nihon Kohden Corporation released its earnings results on Feb 05, 2026. The company reported ¥11.57 earnings per share for the quarter, missing the consensus estimate of ¥12.988 by -¥1.418.
Is Nihon Kohden Corporation overvalued?
According to Wall Street analysts Nihon Kohden Corporation’s price is currently Overvalued.
Does Nihon Kohden Corporation pay dividends?
Nihon Kohden Corporation pays a Semiannually dividend of ¥16 which represents an annual dividend yield of 1.92%. See more information on Nihon Kohden Corporation dividends here
What is Nihon Kohden Corporation’s EPS estimate?
Nihon Kohden Corporation’s EPS estimate is 33.97.
How many shares outstanding does Nihon Kohden Corporation have?
Nihon Kohden Corporation has 170,961,960 shares outstanding.
What happened to Nihon Kohden Corporation’s price movement after its last earnings report?
Nihon Kohden Corporation reported an EPS of ¥11.57 in its last earnings report, missing expectations of ¥12.988. Following the earnings report the stock price went up 1.08%.
Which hedge fund is a major shareholder of Nihon Kohden Corporation?
Currently, no hedge funds are holding shares in JP:6849
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nihon Kohden Corporation
Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Tokyo, Japan.
Technical Analysis
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Rion Co., Ltd.
―
Japan Medical Dynamic Marketing, Inc.
―
Options Prices
Currently, No data available
---